What is the standard usage and dosage of tepotinib?

Tepotinib is a targeted therapy specifically designed to treat non-small cell lung cancer (NSCLC) with exon 14 skipping mutations. Its mechanism of action is to block the proliferation and metastasis of tumor cells by selectively inhibiting the activity of MET receptor tyrosine kinase. Standard usage and dosage are usually determined by doctors based on the patient's specific circumstances. The following are general guidelines for the use of tepotinib.

The standard treatment dose is usually 450mg of tepotinib taken orally once daily. Patients should take this medication at the same time each day as recommended by their doctor, and preferably with food to reduce possible gastrointestinal discomfort. The medicine does not need to be crushed or chewed and can be swallowed whole. Tepotinib is usually available in capsule form, and patients should make sure not to miss any dose when taking the drug every day. If a dose is missed, it should be taken as soon as possible, but if it is close to the time of the next dose, the missed dose should not be taken but should be taken at the normal time.

The use of Tepotinib also requires doctors to make personalized adjustments based on the patient's condition. During treatment, doctors will regularly monitor the patient's health, including liver function, kidney function and lung condition. If a patient experiences serious adverse reactions while taking the medication, the doctor may adjust the dose or temporarily discontinue the medication. For example, liver damage (eg, elevated ALT, AST), lung toxicity (eg, interstitial lung disease), and other serious side effects may require drug use to be suspended and managed. In this case, the doctor will adjust the treatment plan based on the patient's symptoms and response.

In addition, patients should avoid using certain drugs at the same time when taking Tepotinib, because these drugs may interact with Tepotinib, affect its efficacy or aggravate side effects. For example, certain antifungal drugs, antiviral drugs, and certain antibiotics may affect the metabolism of tepotinib. Therefore, patients should consult their doctor when using other medications to ensure safety.

In general, the standard usage of tepotinib is 450 mg orally administered once daily. Patients should take the medication on time according to the guidance of their doctor. During treatment, regular medical examinations and dosage adjustments are essential to ensure the efficacy and safety of the drug. Patients should strictly follow the doctor's advice and promptly report any symptoms of discomfort so that the doctor can make necessary treatment adjustments.

Reference materials:https://www.tepotinib.com/